Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

MRX vs MS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MRX
Marex Group plc Ordinary Shares

Financial - Capital Markets

Financial ServicesNASDAQ • GB
Market Cap$3.60B
5Y Perf.+160.0%
MS
Morgan Stanley

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$307.53B
5Y Perf.+112.8%

MRX vs MS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MRX logoMRX
MS logoMS
IndustryFinancial - Capital MarketsFinancial - Capital Markets
Market Cap$3.60B$307.53B
Revenue (TTM)$3.63B$103.14B
Net Income (TTM)$526M$16.18B
Gross Margin74.7%55.6%
Operating Margin32.0%17.1%
Forward P/E10.2x16.3x
Total Debt$10.17B$360.49B
Cash & Equiv.$6.38B$75.74B

MRX vs MSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MRX
MS
StockApr 24May 26Return
Marex Group plc Ord… (MRX)100260.0+160.0%
Morgan Stanley (MS)100212.8+112.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: MRX vs MS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MS leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. Marex Group plc Ordinary Shares is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
MRX
Marex Group plc Ordinary Shares
The Banking Pick

MRX is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 25.4%, EPS growth 42.3%
  • Lower volatility, beta 0.74, current ratio 3.16x
  • PEG 0.29 vs MS's 1.83
Best for: growth exposure and sleep-well-at-night
MS
Morgan Stanley
The Banking Pick

MS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 11 yrs, beta 1.37, yield 2.0%
  • 7.4% 10Y total return vs MRX's 169.1%
  • NIM 0.7% vs MRX's 0.4%
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthMRX logoMRX25.4% NII/revenue growth vs MS's 16.8%
ValueMRX logoMRXLower P/E (10.2x vs 16.3x), PEG 0.29 vs 1.83
Quality / MarginsMS logoMSEfficiency ratio 0.4% vs MRX's 0.4% (lower = leaner)
Stability / SafetyMRX logoMRXBeta 0.74 vs MS's 1.37
DividendsMS logoMS2.0% yield, 11-year raise streak, vs MRX's 1.5%
Momentum (1Y)MS logoMS+66.7% vs MRX's +9.1%
Efficiency (ROA)MS logoMSEfficiency ratio 0.4% vs MRX's 0.4%

MRX vs MS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MRXMarex Group plc Ordinary Shares

Segment breakdown not available.

MSMorgan Stanley
FY 2024
Wealth Management Segment
45.6%$28.4B
Institutional Securities Segment
45.0%$28.1B
Investment Management Segment
9.4%$5.9B

MRX vs MS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMRXLAGGINGMS

Income & Cash Flow (Last 12 Months)

MRX leads this category, winning 3 of 5 comparable metrics.

MS is the larger business by revenue, generating $103.1B annually — 28.4x MRX's $3.6B. Profitability is closely matched — net margins range from 13.0% (MS) to 8.5% (MRX).

MetricMRX logoMRXMarex Group plc O…MS logoMSMorgan Stanley
RevenueTrailing 12 months$3.6B$103.1B
EBITDAEarnings before interest/tax$2.1B$26.3B
Net IncomeAfter-tax profit$526M$16.2B
Free Cash FlowCash after capex$883M-$6.7B
Gross MarginGross profit ÷ Revenue+74.7%+55.6%
Operating MarginEBIT ÷ Revenue+32.0%+17.1%
Net MarginNet income ÷ Revenue+8.5%+13.0%
FCF MarginFCF ÷ Revenue+18.0%-2.0%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-33.8%+48.9%
MRX leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

MRX leads this category, winning 5 of 6 comparable metrics.

At 12.9x trailing earnings, MRX trades at a 47% valuation discount to MS's 24.3x P/E. Adjusting for growth (PEG ratio), MRX offers better value at 0.32x vs MS's 2.73x — a lower PEG means you pay less per unit of expected earnings growth.

MetricMRX logoMRXMarex Group plc O…MS logoMSMorgan Stanley
Market CapShares × price$3.6B$307.5B
Enterprise ValueMkt cap + debt − cash$7.4B$592.3B
Trailing P/EPrice ÷ TTM EPS12.94x24.31x
Forward P/EPrice ÷ next-FY EPS est.10.23x16.28x
PEG RatioP/E ÷ EPS growth rate0.32x2.73x
EV / EBITDAEnterprise value multiple6.18x26.03x
Price / SalesMarket cap ÷ Revenue0.99x2.98x
Price / BookPrice ÷ Book value/share3.02x2.95x
Price / FCFMarket cap ÷ FCF5.50x
MRX leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

MRX leads this category, winning 8 of 9 comparable metrics.

MRX delivers a 49.7% return on equity — every $100 of shareholder capital generates $50 in annual profit, vs $15 for MS. MS carries lower financial leverage with a 3.42x debt-to-equity ratio, signaling a more conservative balance sheet compared to MRX's 8.05x. On the Piotroski fundamental quality scale (0–9), MRX scores 6/9 vs MS's 5/9, reflecting solid financial health.

MetricMRX logoMRXMarex Group plc O…MS logoMSMorgan Stanley
ROE (TTM)Return on equity+49.7%+14.6%
ROA (TTM)Return on assets+2.0%+1.2%
ROICReturn on invested capital+9.4%+2.9%
ROCEReturn on capital employed+7.9%+3.8%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage8.05x3.42x
Net DebtTotal debt minus cash$3.8B$284.7B
Cash & Equiv.Liquid assets$6.4B$75.7B
Total DebtShort + long-term debt$10.2B$360.5B
Interest CoverageEBIT ÷ Interest expense1.54x0.44x
MRX leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

MRX leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in MRX five years ago would be worth $26,909 today (with dividends reinvested), compared to $24,217 for MS. Over the past 12 months, MS leads with a +66.7% total return vs MRX's +9.1%. The 3-year compound annual growth rate (CAGR) favors MRX at 39.1% vs MS's 34.3% — a key indicator of consistent wealth creation.

MetricMRX logoMRXMarex Group plc O…MS logoMSMorgan Stanley
YTD ReturnYear-to-date+32.4%+7.4%
1-Year ReturnPast 12 months+9.1%+66.7%
3-Year ReturnCumulative with dividends+169.1%+142.1%
5-Year ReturnCumulative with dividends+169.1%+142.2%
10-Year ReturnCumulative with dividends+169.1%+739.4%
CAGR (3Y)Annualised 3-year return+39.1%+34.3%
MRX leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MRX and MS each lead in 1 of 2 comparable metrics.

MRX is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than MS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 99.2% from its 52-week high vs MRX's 91.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMRX logoMRXMarex Group plc O…MS logoMSMorgan Stanley
Beta (5Y)Sensitivity to S&P 5000.74x1.37x
52-Week HighHighest price in past year$54.60$194.83
52-Week LowLowest price in past year$27.91$117.21
% of 52W HighCurrent price vs 52-week peak+91.7%+99.2%
RSI (14)Momentum oscillator 0–10066.861.2
Avg Volume (50D)Average daily shares traded1.1M5.4M
Evenly matched — MRX and MS each lead in 1 of 2 comparable metrics.

Analyst Outlook

MS leads this category, winning 2 of 2 comparable metrics.

Wall Street rates MRX as "Buy" and MS as "Buy". Consensus price targets imply 9.8% upside for MRX (target: $55) vs 6.5% for MS (target: $206). For income investors, MS offers the higher dividend yield at 1.97% vs MRX's 1.46%.

MetricMRX logoMRXMarex Group plc O…MS logoMSMorgan Stanley
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$55.00$205.75
# AnalystsCovering analysts652
Dividend YieldAnnual dividend ÷ price+1.5%+2.0%
Dividend StreakConsecutive years of raises011
Dividend / ShareAnnual DPS$0.73$3.81
Buyback YieldShare repurchases ÷ mkt cap+1.2%+1.4%
MS leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

MRX leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). MS leads in 1 (Analyst Outlook). 1 tied.

Best OverallMarex Group plc Ordinary Sh… (MRX)Leads 4 of 6 categories
Loading custom metrics...

MRX vs MS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is MRX or MS a better buy right now?

For growth investors, Marex Group plc Ordinary Shares (MRX) is the stronger pick with 25.

4% revenue growth year-over-year, versus 16. 8% for Morgan Stanley (MS). Marex Group plc Ordinary Shares (MRX) offers the better valuation at 12. 9x trailing P/E (10. 2x forward), making it the more compelling value choice. Analysts rate Marex Group plc Ordinary Shares (MRX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MRX or MS?

On trailing P/E, Marex Group plc Ordinary Shares (MRX) is the cheapest at 12.

9x versus Morgan Stanley at 24. 3x. On forward P/E, Marex Group plc Ordinary Shares is actually cheaper at 10. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Marex Group plc Ordinary Shares wins at 0. 29x versus Morgan Stanley's 1. 83x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — MRX or MS?

Over the past 5 years, Marex Group plc Ordinary Shares (MRX) delivered a total return of +169.

1%, compared to +142. 2% for Morgan Stanley (MS). Over 10 years, the gap is even starker: MS returned +739. 4% versus MRX's +169. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MRX or MS?

By beta (market sensitivity over 5 years), Marex Group plc Ordinary Shares (MRX) is the lower-risk stock at 0.

74β versus Morgan Stanley's 1. 37β — meaning MS is approximately 85% more volatile than MRX relative to the S&P 500. On balance sheet safety, Morgan Stanley (MS) carries a lower debt/equity ratio of 3% versus 8% for Marex Group plc Ordinary Shares — giving it more financial flexibility in a downturn.

05

Which is growing faster — MRX or MS?

By revenue growth (latest reported year), Marex Group plc Ordinary Shares (MRX) is pulling ahead at 25.

4% versus 16. 8% for Morgan Stanley (MS). On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 53. 5% year-over-year, compared to 42. 3% for Marex Group plc Ordinary Shares. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MRX or MS?

Morgan Stanley (MS) is the more profitable company, earning 13.

0% net margin versus 8. 5% for Marex Group plc Ordinary Shares — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MRX leads at 32. 0% versus 17. 1% for MS. At the gross margin level — before operating expenses — MRX leads at 74. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MRX or MS more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Marex Group plc Ordinary Shares (MRX) is the more undervalued stock at a PEG of 0. 29x versus Morgan Stanley's 1. 83x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Marex Group plc Ordinary Shares (MRX) trades at 10. 2x forward P/E versus 16. 3x for Morgan Stanley — 6. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MRX: 9. 8% to $55. 00.

08

Which pays a better dividend — MRX or MS?

All stocks in this comparison pay dividends.

Morgan Stanley (MS) offers the highest yield at 2. 0%, versus 1. 5% for Marex Group plc Ordinary Shares (MRX).

09

Is MRX or MS better for a retirement portfolio?

For long-horizon retirement investors, Marex Group plc Ordinary Shares (MRX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

74), 1. 5% yield, +169. 1% 10Y return). Both have compounded well over 10 years (MRX: +169. 1%, MS: +739. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MRX and MS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

MRX

High-Growth Disruptor

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Net Margin > 5%
Run This Screen
Stocks Like

MS

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MRX and MS on the metrics below

Revenue Growth>
%
(MRX: 25.4% · MS: 16.8%)
Net Margin>
%
(MRX: 8.5% · MS: 13.0%)
P/E Ratio<
x
(MRX: 12.9x · MS: 24.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.